Xencor Inc

NEW
NAS:XNCR (USA)  
$ 11.05 -0.77 (-6.47%) 07:08 PM EST
At Loss
P/B:
1.15
Market Cap:
$ 778.96M
Enterprise V:
$ 563.45M
Volume:
815.08K
Avg Vol (2M):
617.23K
Trade In:
What is a stock summary page? Click here for an overview.
Volume:
815.08K
At Loss
Avg Vol (2M):
617.23K

Business Description

Description
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.
Name Current Vs Industry Vs History
Cash-To-Debt 2.15
Equity-to-Asset 0.71
Debt-to-Equity 0.34
Debt-to-EBITDA -1.25
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.69
Distress
Grey
Safe
Beneish M-Score 0.07
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 6.61
Quick Ratio 6.61
Cash Ratio 5.69
Days Sales Outstanding 83.54

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -5.8
Shareholder Yield % -27.92

Financials (Next Earnings Date:2025-05-09 Est.)

XNCR's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:XNCR

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

Xencor Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 110.493
EPS (TTM) ($) -3.63
Beta 0.74
3-Year Sharpe Ratio -0.4
3-Year Sortino Ratio -0.57
Volatility % 50.53
14-Day RSI 24.48
14-Day ATR ($) 0.735912
20-Day SMA ($) 13.5485
12-1 Month Momentum % -33.21
52-Week Range ($) 11.02 - 27.24
Shares Outstanding (Mil) 70.46

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Xencor Inc Filings

Filing Date Document Date Form
No Filing Data

Xencor Inc Stock Events

Financials Calendars
Event Date Price ($)
No Event Data

Xencor Inc Frequently Asked Questions

What is Xencor Inc(XNCR)'s stock price today?
The current price of XNCR is $11.06. The 52 week high of XNCR is $27.24 and 52 week low is $11.02.
When is next earnings date of Xencor Inc(XNCR)?
The next earnings date of Xencor Inc(XNCR) is 2025-05-09 Est..
Does Xencor Inc(XNCR) pay dividends? If so, how much?
Xencor Inc(XNCR) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1